Pular para o conteúdo principal
Ranking Invest

ZTS - Zoetis Inc.

Segmento: HealthcareZoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Análise Ranking Invest

Valuation estimado
$ 11.38 Bi
Valor de Mercado
$ 30.15 Bi
Sobrepreço (AV)+165.0%
IVR
0.38A companhia vale 0,38 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
0.30O valuation alternativo equivale a 30% do valor de mercado da companhia.
MLL
0.30O lucro líquido dos controladores em 16 trimestres equivale a 30% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 3.15 Bi

Dívida Líquida

$ 7.57 Bi

L4T

$ 2.62 Bi

MM4T

27.47%

Indicadores Básicos

ROE

83.10%

Índices de Previsibilidade

Receita Líquida

B0.03

Lucro

A0.07

Margem

A0.06

Índices de Tendência

Receita Líquida

B10.11

Lucro

B7.59

Margem

C2.76

Índices de Endividamento

DIV/PAT

2.41

DIV/L4T

2.89

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.